Charles E. Zogzas

Charles E. Zogzas

Auto-generated profile, based on publicly available information

Charles E. Zogzas

From the Division of Pharmacology and Toxicology, College of Pharmacy, Institute for Cellular and Molecular Biology, and Institute for Neuroscience, University of Texas at Austin, Austin, Texas 78712 and

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2014 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
DLDinorah Leyva-Illades
Dinorah Leyva-Illades
PCPan Chen
Pan Chen
CZCharles E. Zogzas
Charles E. Zogzas
SHSteven Hutchens
Steven Hutchens
JMJonathan M. Mercado
Jonathan M. Mercado
SMSomshuvra Mukhopadhyay
Somshuvra Mukhopadhyay
Manganese (Mn) is an essential metal, but elevated cellular levels are toxic and may lead to the development of an irreversible parkinsonian-like syndrome that has no treatment. Mn-induced parkinsonism generally occurs as a result of exposure to elevated Mn levels in occupational or environmental settings. Additionally, patients with compromised liver function attributable to diseases, such as cirrhosis, fail to excrete Mn and may develop Mn-induced parkinsonism in the absence of exposure to elevated Mn. Recently, a new form of familial parkinsonism was reported to occur as a result of mutations inSLC30A10. The cellular function of SLC30A10 and the mechanisms by which mutations in this protein cause parkinsonism are unclear. Here, using a combination of mechanistic and functional studies in cell culture,Caenorhabditis elegans, and primary midbrain neurons, we show that SLC30A10 is a cell surface-localized Mn efflux transporter that reduces cellular Mn levels and protects against Mn-induced toxicity. Importantly, mutations in SLC30A10 that cause familial parkinsonism blocked the ability of the transporter to traffic to the cell surface and to mediate Mn efflux. Although expression of disease-causing SLC30A10 mutations were not deleterious by themselves, neurons and worms expressing these mutants exhibited enhanced sensitivity to Mn toxicity. Our results provide novel insights into the mechanisms involved in the onset of a familial form of parkinsonism and highlight the possibility of using enhanced Mn efflux as a therapeutic strategy for the potential management of Mn-induced parkinsonism, including that occurring as a result of mutations inSLC30A10.

1 July 2016 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
CZCharles E. Zogzas
Charles E. Zogzas
MAMichael Aschner
Michael Aschner
SMSomshuvra Mukhopadhyay
Somshuvra Mukhopadhyay
Homozygous mutations in SLC30A10 lead to the development of familial manganese-induced parkinsonism. We previously demonstrated that SLC30A10 is a cell surface-localized manganese efflux transporter, and parkinsonism-causing mutations block its trafficking and efflux activity. Interestingly, other transporters in the SLC30 family mediate zinc efflux. Determining the mechanisms that allow SLC30A10 to transport manganese, which are unclear, is essential to understand its role in parkinsonism. Here, we generated a predicted structure of SLC30A10, based on the structure of the bacterial zinc transporter YiiP, and performed functional studies. In YiiP, side chains of residues Asp-45 and Asp-49 in the second and His-153 and Asp-157 in the fifth transmembrane segments coordinate zinc and are required for transport. In SLC30A10, the corresponding residues are Asn-43 and Asp-47 in the second and His-244 and Asp-248 in the fifth transmembrane segments. Surprisingly, although alanine substitution of Asp-248 abolished manganese efflux, that of Asn-43 and Asp-47 did not. Instead, side chains of charged or polar residues adjacent to Asp-248 in the first (Glu-25) or fourth (Asn-127) transmembrane segments were required. Further analyses revealed that residues His-333 and His-350 in the cytoplasmic C-terminal domain were required for full activity. However, the C-terminal domain failed to transfer manganese transport capability to a related zinc transporter. Overall, our results indicate that residues in the transmembrane and C-terminal domains together confer optimal manganese transport capability to SLC30A10 and suggest that the mechanism of ion coordination in the transmembrane domain of SLC30A10 may be substantially different from that in YiiP/other SLC30 proteins.

1 March 2016 in Journal of Structural Biology
Verified
Journal Article
Closed access
DGDarren C. Gay
Darren C. Gay
DWDrew T. Wagner
Drew T. Wagner
JMJessica L. Meinke
Jessica L. Meinke
CZCharles E. Zogzas
Charles E. Zogzas
GGGlen R. Gay
Glen R. Gay
AKAdrian T. Keatinge-Clay
Adrian T. Keatinge-Clay

1 November 2014 in Biochimica et Biophysica Acta (BBA) - Bioenergetics
Verified
Journal Article
Closed access
LKLucas Kressel
Lucas Kressel
KFKaitlyn M. Faries
Kaitlyn M. Faries
MWMarc J. Wander
Marc J. Wander
CZCharles E. Zogzas
Charles E. Zogzas
RMRachel J. Mejdrich
Rachel J. Mejdrich
CKChristine Kirmaier
Christine Kirmaier